EFTA01017715
EFTA01017716 DataSet-9
EFTA01017718

EFTA01017716.pdf

DataSet-9 2 pages 503 words document
P17 V16 P19 P21 D8
Open PDF directly ↗ View extracted text
👁 1 💬 0
📄 Extracted Text (503 words)
From: Boris Nikolic To: ' CC: "jeevacationggrnail.com" <jeevacationggrnail.com> Subject: RE: Re: Date: Sat, 03 Nov 2018 17:27:02 +0000 Thank you Harry! Again — great meeting you. I am still laughing re inherited STD. Finally I had chance to read your slide deck. VERU is indeed very interesting company — congrats! You have an interesting mix of Urology specialty drugs (which I see as a low risk) and Prostate cancer drugs. Unfortunately my fund (https://www.biomaticscapital.com/) is only focused (and restricted to investing) on private companies. Mid-end of the next year I am going to fundraise a crossover fund which would allow me to invest in both private and publicly listed companies; nevertheless, I am now unable to invest in companies such as VERU — despite how interesting they might be. I looked at a female condom. I think that PATH supported a number of related projects. https://www.path.org/articles/seven-secrets-of-the-female-condom/ As you might know BMGF is the main donor to PATH — this is why I mentioned it. Also BMGF founded several smaller grants (GCE) re female condoms https://www.gatesfoundation.org/Media- Center/Press-Releases/2014/06/GCE-Round-12 In addition, there were grants to Imperial College in London, HealthRock etc. All of these are relatively old grants that ended. My guess is that all female condom more mature projects transitioned to PATH. Also I see that PSI has been funding marketing and delivery https://www.psi.org/2018/03/fresh-start-female-condom- marketing( Please let me know if there is anything else I can be of help to you. Hope to see you soon in NYC Best Boris From: Sent: Thursday, November 1, 2018 5:34 PM To: Boris Nikolic >; [email protected] Subject: Re: Jeffrey thanks for introducing me to Boris. Boris, great meeting you as well. Attached is the most recent deck for VERU (NASDAQ: VERU) www.verupharma.com . In addition please look at www.femalecondom.com. We merged with The Female Health Company which sells the FC2 Female Condom to the public sector in Africa and Brazil via UNFPA and USAID. We just recently introduced this condom EFTA01017716 into the US market mainly via telemedicine. Would love to meet and discuss further. Sincerely, Harry Harry Fisch MD cell 914-552-2651 Original Message From: Boris Nikolic < > To: J <[email protected]>. Harry Fisch < > Sent: Thu, Nov 1, 2018 4:13 pm Subject: RE: Thank you J! Great meeting you Harry! Looking forward to seeing you again. Please send me something re your company. Best Boris From: 1 <[email protected]> Sent: Thursday, November 1, 2018 3:15 PM To: Boris Nikolic Harry Fisch < Subject: harry boris , boris harry please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected] and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA01017717
ℹ️ Document Details
SHA-256
97e8dd5860094b02292d838ee86b0a875e47563cc9b03fe4c427ce1372d465f6
Bates Number
EFTA01017716
Dataset
DataSet-9
Document Type
document
Pages
2

Comments 0

Loading comments…
Link copied!